Research classified by Journal of Economic Literature (JEL) codes

2015

• Luciana Lazzeretti & Francesco Capone, 2015, "Resilience, creativity and innovation. The case of Chemical innovations after the 1966 Flood in Florence," Working Papers - Business, Universita' degli Studi di Firenze, Dipartimento di Scienze per l'Economia e l'Impresa, number wp2015_01.rdf.
• Christian Dianoux & Jean-Luc Herrmann & Ridha Chakroun & Sandrine Heitz-Spahn, 2015, "Comparative versus Noncomparative Sales Pitches: Impact on New Product Buying Behaviors and Moderating Role of Buyer-Seller Relationship," Post-Print, HAL, number hal-01370234, DOI: 10.19030/jabr.v31i4.9333.
• Cédric Brun & Steeves Demazeux & Pierangelo Di Vittorio & François Gonon & Philippe Gorry & Jan Peter Konsman & Fanny Lung & Yannick Lung & Michel Minard & Matthieu Montalban & Nicole Rumeau & Andy Sm, 2015, "Construction of mental health categories
  [La construction des catégories diagnostiques de maladie mentale]," Post-Print, HAL, number hal-02195583, DOI: 10.4000/regulation.11299.
• Diego Useche & Philippe Gorry, 2015, "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print, HAL, number hal-02195963, Jun.
• Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015, "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print, HAL, number hal-03148867.
• Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015, "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print, HAL, number hal-03152236.
• Izabela Jelovac, 2015, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print, HAL, number halshs-01178630, Apr.
• Izabela Jelovac, 2015, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print, HAL, number halshs-01178631, Apr.
• Izabela Jelovac, 2015, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print, HAL, number halshs-01178636, May.
• Izabela Jelovac & Nicolas Houy, 2015, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print, HAL, number halshs-01261578, Nov.
• Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015, "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 11/2015, Jun.
• HONJO, Yuji & 本庄, 裕司 & NAGAOKA, Sadao & 長岡, 貞男, 2015, "Initial Public Offering and Financing of Biotechnology Start-ups: Evidence from Japan," IIR Working Paper, Institute of Innovation Research, Hitotsubashi University, number 15-20, Sep.
• Agud Eliza Maria, 2015, "In vitro alteration of some taxoni in danger of extinction from protected areas from Bihor country (drosera rotundifolia huds.)," Impact of Socio-economic and Technological Transformations at National, European and International Level (ISETT), Institute for World Economy, Romanian Academy, volume 2.
• João Carlos Lopes & Ana Santos, 2015, "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Working Papers Department of Economics, ISEG - Lisbon School of Economics and Management, Department of Economics, Universidade de Lisboa, number 2015/12, Jul.
• Chen-Ming Chen & Tzu-Chun Sheng & Yung-Lieh Yang, 2015, "Market Structure, Government Shareholding and Cost Efficiency in Taiwan's Biotech Industry," Journal of Economics and Management, College of Business, Feng Chia University, Taiwan, volume 11, issue 1, pages 69-100, January.
• Marilena Locatelli & Steinar Strøm, 2015, "Longitudinal Analysis of Generic Substitution," Atlantic Economic Journal, Springer;International Atlantic Economic Society, volume 43, issue 3, pages 363-374, September, DOI: 10.1007/s11293-015-9462-6.
• Tannista Banerjee & Arnab Nayak, 2015, "Comparing Domestic and Cross-Border Mergers and Acquisitions in the Pharmaceutical Industry," Atlantic Economic Journal, Springer;International Atlantic Economic Society, volume 43, issue 4, pages 489-499, December, DOI: 10.1007/s11293-015-9476-0.
• Frank Lichtenberg, 2015, "The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011," International Journal of Health Economics and Management, Springer, volume 15, issue 3, pages 339-359, September, DOI: 10.1007/s10754-015-9172-2.
• Badi Baltagi & Peter Egger & Michaela Kesina, 2015, "Sources of productivity spillovers: panel data evidence from China," Journal of Productivity Analysis, Springer, volume 43, issue 3, pages 389-402, June, DOI: 10.1007/s11123-014-0393-z.
• Antonio Malva & Stijn Kelchtermans & Bart Leten & Reinhilde Veugelers, 2015, "Basic science as a prescription for breakthrough inventions in the pharmaceutical industry," The Journal of Technology Transfer, Springer, volume 40, issue 4, pages 670-695, August, DOI: 10.1007/s10961-014-9362-y.
• Santosh K. Sahu & Nitika Agarwal, 2015, "Mergers and Acquisitions in the Indian Pharmaceutical Sector," Working Papers, Madras School of Economics,Chennai,India, number 2015-122, Sep.
• Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015, "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," MAGKS Papers on Economics, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung), number 201527.
• Richard T. Thakor & Andrew W. Lo, 2015, "Competition and R&D Financing Decisions: Theory and Evidence from the Biopharmaceutical Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 20903, Jan.
• María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015, "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers, National Bureau of Economic Research, Inc, number 20995, Feb.
• Vincenzo Palermo & Matthew J. Higgins & Marco Ceccagnoli, 2015, "Assets with "Warts": How Reliable is the Market for Technology?," NBER Working Papers, National Bureau of Economic Research, Inc, number 21103, Apr.
• Mark R. Trusheim & Ernst R. Berndt, 2015, "An Overview of the Stratified Economics of Stratified Medicine," NBER Working Papers, National Bureau of Economic Research, Inc, number 21233, Jun.
• Frank R. Lichtenberg, 2015, "The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011," NBER Working Papers, National Bureau of Economic Research, Inc, number 21239, Jun.
• Marco Ceccagnoli & Matthew J. Higgins & Hyunsung D. Kang, 2015, "Corporate Venture Capital as a Real Option in the Markets for Technology," NBER Working Papers, National Bureau of Economic Research, Inc, number 21424, Jul.
• Kurt R. Brekke & Chiara Canta & Odd Rune StraumeAuthor-Email: o.r.straume@eeg.uminho.p, 2015, "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," NIPE Working Papers, NIPE - Universidade do Minho, number 6/2015.
• Haakonsson, Stine Jessen & Ujjual, Vandana, 2015, "Internationalisation of R&D: New insights into multinational enterprises’ R&D strategies in emerging markets," management revue - Socio-Economic Studies, Nomos Verlagsgesellschaft mbH & Co. KG, volume 26, issue 2, pages 101-122.
• Suzuki, Osamu, 2015, "Unpacking performance benefits of innovation ambidexterity: Evidence from the pharmaceutical industry," management revue - Socio-Economic Studies, Nomos Verlagsgesellschaft mbH & Co. KG, volume 26, issue 4, pages 328-348.
• Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2015, "The technological resilience of US cities," Cambridge Journal of Regions, Economy and Society, Cambridge Political Economy Society, volume 8, issue 2, pages 167-184.
• Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2015, "Relatedness and technological change in cities: the rise and fall of technological knowledge in US metropolitan areas from 1981 to 2010," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, volume 24, issue 1, pages 223-250.
• Margaritti Doina & Tomos Sirma, 2015, "How the Distribution System and the Granting of Drug Discounts, is an Influencing Factor for a Pharmaceutical Units’ Financial Performance," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, volume 0, issue 1, pages 803-808, May.
• Amin Babaei Falah & Morteza Sardari, 2015, "A novel application of grey principal component analysis to determine stockholder’s approach towards financial ratios," Business and Economic Horizons (BEH), Prague Development Center, volume 11, issue 1, pages 41-50, April.
• María José Abud & Bronwyn Hall & Christian Helmers, 2015, "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, volume 10, issue 4, pages 1-17, April, DOI: 10.1371/journal.pone.0124257.
• Krammer, Sorin M.S., 2015, "The role of diversification profiles and dyadic characteristics in the formation of technological alliances: Differences between exploitation and exploration in a low-tech industry," MPRA Paper, University Library of Munich, Germany, number 64843, Jun.
• Haakonsson, Stine Jessen & Ujjual, Vandana, 2015, "Internationalisation of R&D: New insights into multinational enterprises’ R&D strategies in emerging markets," management revue. Socio-economic Studies, Rainer Hampp Verlag, volume 26, issue 2, pages 101-122.
• Suzuki, Osamu, 2015, "Unpacking performance benefits of innovation ambidexterity: Evidence from the pharmaceutical industry," management revue. Socio-economic Studies, Rainer Hampp Verlag, volume 26, issue 4, pages 328-348.
• Manon JUBIEN, 2015, "Les innovations de produits dans la chimie du végétal comme substituts aux plastiques
  [Products innovation in bio-based chemistry as a subtitute to plastics]," Working Papers, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation, number 293, Feb.
• Irina Ipatova, 2015, "The dynamics of total factor productivity and its components: Russian plastic production," Applied Econometrics, Russian Presidential Academy of National Economy and Public Administration (RANEPA), volume 38, issue 2, pages 21-40.
• Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015, "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, volume 17.
• Jitendra Kumar Chaudhary, 2015, "Harnessing stem cell potential for regenerative medicine and cell-based therapy," Journal of Studies in Dynamics and Change (JSDC), ISSN: 2348-7038, Voices of Inclusive Change and Expressions- (VOICE) Trust, Dehradun, Uttarakhand, volume 2, issue 1, pages 339-343, January.
• João Lopes & Ana Santos, 2015, "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Proceedings of Business and Management Conferences, International Institute of Social and Economic Sciences, number 3105028, Oct.
• Michael Mueller & Alexander Frenzel, 2015, "Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 16, issue 1, pages 73-82, January, DOI: 10.1007/s10198-013-0555-3.
• David Granlund & Miyase Koksal-Ayhan, 2015, "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 16, issue 9, pages 969-983, December, DOI: 10.1007/s10198-014-0646-9.
• Anne Boring, 2015, "The impact of patent protection on US pharmaceutical exports to developing countries," Applied Economics, Taylor & Francis Journals, volume 47, issue 13, pages 1314-1330, March, DOI: 10.1080/00036846.2014.995364.
• Frank R. Lichtenberg, 2015, "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," International Journal of the Economics of Business, Taylor & Francis Journals, volume 22, issue 2, pages 277-299, July, DOI: 10.1080/13571516.2015.1045743.
• Vincent K.K. Leung & Marco Chi Keung Lau & Zhe Zhang & Flora F. Gu, 2015, "Explorative versus exploitative alliances: evidence from the glass industry in China," Journal of Chinese Economic and Business Studies, Taylor & Francis Journals, volume 13, issue 2, pages 127-146, May, DOI: 10.1080/14765284.2015.1021115.
• Lorenzo Cassi & Anne Plunket, 2015, "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Regional Studies, Taylor & Francis Journals, volume 49, issue 6, pages 936-954, June, DOI: 10.1080/00343404.2013.816412.
• Nicolas Houy & Izabela Jelovac, 2015, "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., volume 24, issue 8, pages 978-989, August, DOI: 10.1002/hec.3078.
• Tannistra Banerjee & Stephen Martin, 2015, "Pharmaceutical Regulation and Innovative Performance: A Decision‐theoretic Model," Managerial and Decision Economics, John Wiley & Sons, Ltd., volume 36, issue 3, pages 177-190, April.
• Jaime de Melo, 2015, "Developing Countries in the World Economy," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number 8790, ISBN: ARRAY(0x5fca5f08), September.
• Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), 2015, "Effective Technology Transfer in Biotechnology:Best Practice Case Studies in Europe," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number p1002, ISBN: ARRAY(0x60216e58), September.
• Robin De Cock, 2015, "CASE STUDY 1: A Look Inside Imperial College's TTO," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 1, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015, "CASE STUDY 2: Technology Transfer at VIB," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 2, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Magdalena Powierża & Piotr Potepa, 2015, "CASE STUDY 3: The Creation of a New Technology Transfer Office," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 3, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Alexander Funkner & Nadine Schmieder-Galfe & Oliver Uecke, 2015, "CASE STUDY 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The “Dresden Model”," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 4, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Robin De Cock, 2015, "CASE STUDY 5: Environmental Success Factors of Imperial College's TTO," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 5, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015, "CASE STUDY 6: The Industrial Research Fund," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 6, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Regional Development Agency Ostrava, 2015, "CASE STUDY 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology Transfer," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 7, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Magdalena Powierża & Piotr Potepa, 2015, "CASE STUDY 8: Public Funds for Patenting, Valorization and Science–Industry Collaboration," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 8, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Robin De Cock, 2015, "CASE STUDY 9: The Imperial Bioincubator," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 9, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Maarika Merirand & Siim Espenberg, 2015, "CASE STUDY 10: Idea Lab — A Platform for Students to Develop New Ideas," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 10, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck & Marc Goldchstein, 2015, "CASE STUDY 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit Brussel," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 11, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Carlos Lurigados, 2015, "CASE STUDY 12: BioEmprenedorXXI: Guidance Program for Starting up and Growing Companies in the Life Sciences Arena," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 12, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Magdalena Powierża & Piotr Potepa & Hubert Ludwiczak, 2015, "CASE STUDY 13: Education for Scientists," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 13, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Adela Farre & Carlos Lurigados, 2015, "CASE STUDY 14: The Biocat Model: Managing the Bioregion of Catalonia," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 14, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015, "CASE STUDY 15: The Effects of a Cluster on a Spin-Off — The Foundation of Ablynx," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 15, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Regional Development Agency Ostrava, 2015, "CASE STUDY 16: Brokerage Event: Matching International R&D Projects," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 16, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Nadine Schmieder-Galfe & Alexander Funkner & Oliver Uecke, 2015, "CASE STUDY 17: The DRESDEN-concept: A Focus on Shared Services and Facilities," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 17, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse, "EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe".
• Vittorio Corbo & Jaime de Melo & James Tybout, 2015, "What Went Wrong with the Recent Reforms in the Southern Cone," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 2, "Developing Countries in the World Economy".
• Jaime de Melo & James Tybout, 2015, "The Effects of Financial Liberalization on Savings and Investment in Uruguay," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 3, "Developing Countries in the World Economy".
• Shantayanan Devarajan & Jaime de Melo, 2015, "Adjustment with a Fixed Exchange Rate: Cameroon, Côte d'Ivoire, and Senegal," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 4, "Developing Countries in the World Economy".
• Riccardo Faini & Jaime De Melo & Abdelhak Senhadji & Julie Stanton, 2015, "Growth-Oriented Adjustment Programs: A Statistical Analysis," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 5, "Developing Countries in the World Economy".
• Riccardo Faini & Jaime de Melo, 2015, "Adjustment, Investment and the Real Exchange Rate in Developing Countries," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 6, "Developing Countries in the World Economy".
• Céline Carrère & Jaime de Melo, 2015, "Fiscal Spending and Economic Growth: Some Stylized Facts," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 7, "Developing Countries in the World Economy".
• Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2015, "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 8, "Developing Countries in the World Economy".
• Jaime de MELO & Shujiro URATA, 2015, "The Influence of Increased Foreign Competition on Industrial Concentration and Profitability," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 9, "Developing Countries in the World Economy".
• James Tybout & Jaime de Melo & Vittorio Corbo, 2015, "The Effects of Trade Reforms on Scale and Technical Efficiency," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 10, "Developing Countries in the World Economy".
• Jaime de Melo & L. Alan Winters, 2015, "Do Exporters Gain from VERs?," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 11, "Developing Countries in the World Economy".
• Céline Carrère & Jaime de Melo, 2015, "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 12, "Developing Countries in the World Economy".
• Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2015, "Has Distance Died? Evidence from a Panel Gravity Model," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 13, "Developing Countries in the World Economy".
• Jaime De Melo & Arvind Panagariya & Dani Rodrik, 2015, "The New Regionalism: A Country Perspective," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 14, "Developing Countries in the World Economy".
• Olivier Cadot & Jaime de Melo & Marcelo Olarreaga, 2015, "The Protectionist Bias of Duty Drawbacks: Evidence from Mercosur," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 15, "Developing Countries in the World Economy".
• Olivier Cadot & Jaime de Melo, 2015, "Why OECD Countries Should Reform Rules of Origin," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 16, "Developing Countries in the World Economy".
• Jean-Marie Grether & Jaime de Melo & Tobias Müller, 2015, "The Political Economy of International Migration in a Ricardo–Viner Model," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 17, "Developing Countries in the World Economy".
• Sanoussi Bilal & Jean-Marie Grether & Jaime de Melo, 2015, "Attitudes Towards Immigration: A Trade Theoretic Approach," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 18, "Developing Countries in the World Economy".
• Jaime de Melo & Florence Miguet & Tobias Müller, 2015, "The Political Economy of Migration and EU Enlargement: Lessons from Switzerland," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 19, "Developing Countries in the World Economy".
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015, "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 20, "Developing Countries in the World Economy".
• Artjoms IVLEVS & Jaime DE MELO, 2015, "FDI, the Brain Drain and Trade: Channels and Evidence," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 21, "Developing Countries in the World Economy".
• Jean-Marie Grether & Nicole Andréa Mathys & Jaime de Melo, 2015, "Unravelling the Worldwide Pollution Haven Effect," World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd., chapter 23, "Developing Countries in the World Economy".
• Roblek, Vasja & Meško Maja, 2015, "Designing Mobile Application for the Over the Counter Drug Marketing," Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference (2015), Kotor, Montengero, IRENET - Society for Advancing Innovation and Research in Economy, Zagreb, "Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference, Kotor, Montengero, 10-11 September 2015".

2014

• Lynne G. Zucker & Michael R. Darby, 2014, "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Stragtegy," Annals of Economics and Statistics, GENES, issue 115-116, pages 221-251, DOI: 10.15609/annaeconstat2009.115-116.2.
• Petra Moser & Alessandra Voena & Fabian Waldinger, 2014, "German Jewish ?migr?s and US Invention," American Economic Review, American Economic Association, volume 104, issue 10, pages 3222-3255, October.
• Keith M. Marzilli Ericson, 2014, "Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange," American Economic Journal: Economic Policy, American Economic Association, volume 6, issue 1, pages 38-64, February, DOI: 10.1257/pol.6.1.38.
• Dragutinovic, Stefan & Zubovic, Jovan & Reljic, Marija, 2014, "Pharmaceutical Sector in Serbia in the Period 1990-2013," Ekonomika, Journal for Economic Theory and Practice and Social Issues, Society of Economists Ekonomika, Nis, Serbia, volume 60, issue 4, December, DOI: 10.22004/ag.econ.290111.
• Carlos Gustavo Cano, 2014, "Carestía e inflación: qué esperar de la política agrícola y los gravámenes a la tierra y el carbono," Borradores de Economia, Banco de la Republica de Colombia, number 836, Aug, DOI: 10.32468/be.836.
• Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2014, "Behind the Scenes: Sources of Complementarity in R&D," Journal of Economics & Management Strategy, Wiley Blackwell, volume 23, issue 1, pages 125-148, March, DOI: 10.1111/jems.12048.
• Jeitschko Thomas D. & Zhang Nanyun, 2014, "Adverse Effects of Patent Pooling on Product Development and Commercialization," The B.E. Journal of Theoretical Economics, De Gruyter, volume 14, issue 1, pages 27-57, January, DOI: 10.1515/bejte-2013-0038.
• Martino Nieddu & Estelle Garnier & Christophe Bliard, 2014, "Patrimoines productifs collectifs versus exploration/exploitation. Le cas de la bioraffinerie," Revue économique, Presses de Sciences-Po, volume 65, issue 6, pages 957-987.
• Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014, "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers, Centre for Economic Performance, LSE, number dp1298, Sep.
• Manolis Galenianos & Alessandro Gavazza, 2014, "A Quantitative Analysis of the Retail Market for Illicit Drugs," STICERD - Economics of Industry Papers, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE, number 53, Dec.
• Tannista Banerjee & Ralph Siebert, 2014, "The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry," CESifo Working Paper Series, CESifo, number 4567.
• Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014, "Sources of Productivity Spillovers: Panel Data Evidence from China," CESifo Working Paper Series, CESifo, number 4812.
• Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014, "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," CESifo Working Paper Series, CESifo, number 5114.
• Julia Heller & Jan Kluge & Christian Ochsner, 2014, "Stimmt die Chemie? Die Export- und Forschungsstärke der Chemischen und Pharmazeutischen Industrie im Ost-West-Vergleich," ifo Dresden berichtet, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 21, issue 06, pages 11-19, December.
• Evgenia Kudymowa & Klaus Wohlrabe, 2014, "Konjunkturtest im Fokus: Herstellung von Gummi- und Kunststoffwaren," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 67, issue 07, pages 23-26, April.
• Carlos Gustavo Cano, 2014, "Carest�a e inflaci�n: qu� esperar de la pol�tica agr�cola y los grav�menes a la tierra y el carbono," Borradores de Economia, Banco de la Republica, number 12022, Aug.
• Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014, "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 10149, Sep.
• Sylvain Béal & Marc Deschamps, 2014, "On compensation schemes for data sharing within the european REACH legislation," Working Papers, CRESE, number 2014-01, Feb.
• Sylvain Béal & Marc Deschamps & Philippe Solal, 2014, "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers, CRESE, number 2014-02, Aug.
• Boschma, Ron & Heimeriks, Gaston & Balland, Pierre-Alexandre, 2014, "Scientific knowledge dynamics and relatedness in biotech cities," Research Policy, Elsevier, volume 43, issue 1, pages 107-114, DOI: 10.1016/j.respol.2013.07.009.
• Nishimura, Junichi & Okada, Yosuke, 2014, "R&D portfolios and pharmaceutical licensing," Research Policy, Elsevier, volume 43, issue 7, pages 1250-1263, DOI: 10.1016/j.respol.2014.03.008.
• Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2014, "The Technological Resilience of U.S. Cities," Papers in Evolutionary Economic Geography (PEEG), Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, number 1419, Oct, revised Oct 2014.
• Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014, "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library, number 60450, Sep.
• Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014, "German Jewish émigrés and US invention," LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library, number 68322, Oct.
• Stephen Roper & Helen Xia, 2014, "Unpacking open innovation: Absorptive capacity, exploratory and exploitative openness and the growth of entrepreneurial biopharmaceutical firms," Research Papers, Enterprise Research Centre, number 0019, May.
• William S. Comanor & Stuart O. Schweitzer, 2014, "Pharmaceutical economics," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, volume 2014, issue 1, pages 55-82.
• Nicolas Houy & Izabela Jelovac, 2014, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Etienne (GATE Lyon St-Etienne), Université de Lyon, number 1425.
• Lorenzo Cassi & Anne Plunket, 2014, "Proximity, network formation and inventive performance: in search of the proximity paradox," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers), HAL, number hal-00997650, Sep, DOI: 10.1007/s00168-014-0612-6.
• Lorenzo Cassi & Anne Plunket, 2014, "Proximity, network formation and inventive performance: in search of the proximity paradox," Post-Print, HAL, number hal-00997650, Sep, DOI: 10.1007/s00168-014-0612-6.
• Nicolas Houy & Izabela Jelovac, 2014, "Drug launch timing and international reference pricing," Post-Print, HAL, number halshs-00993816, Jul, DOI: 10.1002/hec.3078.
• Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2014, "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Post-Print, HAL, number halshs-01074524.
• Izabela Jelovac & Nicolas Houy, 2014, "Drug launch timing and international reference pricing," Post-Print, HAL, number halshs-01088164, Sep.
• Nicolas Houy & Izabela Jelovac, 2014, "Drug launch timing and international reference pricing," Post-Print, HAL, number halshs-01096276, Jun.
• Sylvain Béal & Marc Deschamps, 2016, "On compensation schemes for data sharing within the European REACH legislation," Post-Print, HAL, number halshs-01111885, DOI: 10.1007/s10657-014-9468-6.
• Izabela Jelovac, 2014, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print, HAL, number halshs-01138229, Dec.
• Sylvain Béal & Marc Deschamps & Philippe Solal, 2014, "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers, HAL, number hal-01377926, Feb.
• Nicolas Houy & Izabela Jelovac, 2014, "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers, HAL, number halshs-01072741.
• Bergman, Mats & Granlund, David & Rudholm, Niklas, 2014, "Reforming the Swedish pharmaceuticals market – consequences for costs per defined daily dose," HUI Working Papers, HUI Research, number 105, Jun.
• Balland, Pierre-Alexandre & Rigby, David & Boschma, Ron, 2014, "The Technological Resilience of U.S. Cities," Papers in Innovation Studies, Lund University, CIRCLE - Centre for Innovation Research, number 2014/32, Dec.
• Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014, "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 1/2014, Jan.
• Samuel Yaw Akomea & Olav Jull Sørensen & Kweku Amponsah-Efah, 2014, "Export Drivers And Barriers: Evidence From Ghanaian Pharmaceutical Manufacturing Firms," Global Journal of Business Research, The Institute for Business and Finance Research, volume 8, issue 2, pages 81-96.
• Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014, "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, volume 234, issue 2-3, pages 274-298, April, DOI: 10.1515/jbnst-2014-2-310.
• Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014, "German Jewish Emigres and US Invention," Munich Reprints in Economics, University of Munich, Department of Economics, number 68900.
• Badi H. Baltagi & Peter H. Egger, 2014, "Firm-Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers, Center for Policy Research, Maxwell School, Syracuse University, number 173, Dec.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2014, "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers, Center for Policy Research, Maxwell School, Syracuse University, number 175, Dec.
• Talia Bar & Dean R. Lillard, 2014, "Direct to Consumer Advertising of Pharmaceutical Drugs: Information and Persuasion," NBER Working Papers, National Bureau of Economic Research, Inc, number 19794, Jan.
• Eduardo Morales & Gloria Sheu & Andrés Zahler, 2014, "Gravity and Extended Gravity: Using Moment Inequalities to Estimate a Model of Export Entry," NBER Working Papers, National Bureau of Economic Research, Inc, number 19916, Feb.
• Rena M. Conti & Ernst R. Berndt, 2014, "Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007," NBER Working Papers, National Bureau of Economic Research, Inc, number 20016, Mar.
• Lynne G. Zucker & Michael R. Darby, 2014, "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Strategy," NBER Working Papers, National Bureau of Economic Research, Inc, number 20249, Jun.
• Keith M. Drake & Martha A. Starr & Thomas McGuire, 2014, "Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?," NBER Working Papers, National Bureau of Economic Research, Inc, number 20292, Jul.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014, "Patents and the Global Diffusion of New Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 20492, Sep.
• Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014, "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers, National Bureau of Economic Research, Inc, number 20532, Sep.
• Braginskij, O. & Tatevosjan, G. & Sedova, S., 2014, "Methodology of Investment Programs' Studying and Its Optimization in Bounded Financial Resources (the Example of Chemical Industry)," Journal of the New Economic Association, New Economic Association, volume 23, issue 3, pages 130-152.
• Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014, "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers, NIPE - Universidade do Minho, number 01/2014.
• Frank R. Lichtenberg, 2014, "Has Medical Innovation Reduced Cancer Mortality?," CESifo Economic Studies, CESifo Group, volume 60, issue 1, pages 135-177.
• Gaston Heimeriks & Ron Boschma, 2014, "The path- and place-dependent nature of scientific knowledge production in biotech 1986–2008," Journal of Economic Geography, Oxford University Press, volume 14, issue 2, pages 339-364.
• Margaritti Doina, 2014, "A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, volume 0, issue 2, pages 119-131, May.
• Mannino, Ilda & Ninka, Eniel & Turvani, Margherita, 2014, "Porto Marghera and the Industrial Ecology Challenge: Why it did not become an Eco-Industrial Park," MPRA Paper, University Library of Munich, Germany, number 55166, Apr.
• Kuzyaeva, Anastasia & Didenko, Alexander, 2014, "Productivity Spillovers in the Russian Federation: The Case of Chemical Market," MPRA Paper, University Library of Munich, Germany, number 59349, Sep.
• Paolo Sylos Labini, 2014, "Montedison. Il dinosauro nel MEC," Moneta e Credito, Economia civile, volume 67, issue 265, pages 69-76.
• Manolis Galenianos & Alessandro Gavazza, 2014, "A quantitative analysis of the retail market for illicit drugs," 2014 Meeting Papers, Society for Economic Dynamics, number 618.
• Mishra SOVANJEET, 2014, "HR Issues and Challenges in Pharmaceuticals with special reference to India," REVISTA DE MANAGEMENT COMPARAT INTERNATIONAL/REVIEW OF INTERNATIONAL COMPARATIVE MANAGEMENT, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, volume 15, issue 4, pages 423-430, October.
• Kuzyaeva Anastasia & Didenko Alexander, 2014, "Productivity spillovers in the Russian Federation: the case of the chemical market," Review of Business and Economics Studies, CyberLeninka;Федеральное государственное образовательное бюджетное учреждение высшего профессионального образования «Финансовый университет при Правительстве Российской Федерации» (Финансовый университет), issue 3, pages 55-74.
• Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014, "The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India," Discussion Papers, Stanford Institute for Economic Policy Research, number 14-005, Oct.
• Lorenzo Cassi & Anne Plunket, 2014, "Proximity, network formation and inventive performance: in search of the proximity paradox," The Annals of Regional Science, Springer;Western Regional Science Association, volume 53, issue 2, pages 395-422, September, DOI: 10.1007/s00168-014-0612-6.
• Javier Coronado & Sergi Jiménez-Martín & Pedro Marín, 2014, "An empirical analysis of the multimarket contact theory in pharmaceutical markets," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 15, issue 6, pages 623-643, July, DOI: 10.1007/s10198-013-0501-4.
• Frank R. Lichtenberg & Billie Pettersson, 2014, "The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 23, issue 3, pages 239-273, April, DOI: 10.1080/10438599.2013.828456.
• Steven Tenn & Brett W. Wendling, 2014, "Entry Threats and Pricing in the Generic Drug Industry," The Review of Economics and Statistics, MIT Press, volume 96, issue 2, pages 214-228, May.
• Carlos Bianchi, 2014, "Biotechnological firms in Uruguay 2010-2012," Documentos de Trabajo (working papers), Instituto de Economía - IECON, number 14-24, Dec.
• Philippe Abecassis & Nathalie Coutinet, 2014, "Les transformations du modèle de l’industrie pharmaceutique," CEPN Policy Brief, Centre d'Economie de l'Université de Paris Nord, volume 4, pages 1-4.
• Philippe Abecassis & Nathalie Coutinet, 2014, "How the pharmaceutical business model has changed," CEPN Policy Brief, Centre d'Economie de l'Université de Paris Nord, volume 4, pages 1-4.
• Christian Zeller & Andreas Hametner & Koen Smet & Markus Seiwald, 2014, "Internationale Expansion in der pharmazeutischen Industrie Österreichs," FIW Research Reports series, FIW, number V-004, Apr.
• Kirchhoff, Jasmina, 2014, "Regionale Beschäftigungsstruktur wissensintensiver Industrien am Beispiel der Pharmabranche," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 41, issue 3, pages 105-122, DOI: 10.2373/1864-810X.14-03-05.

2013

• Niels Skipper & Rune Vejlin, 2013, "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers, Department of Economics and Business Economics, Aarhus University, number 2013-05, Mar.
• Tannista Banerjee & Ralph Siebert, 2013, "The Impact of R&D Cooperation on Drug Variety Offered on the Market: Evidence from the Pharmaceutical Industry," Auburn Economics Working Paper Series, Department of Economics, Auburn University, number auwp2013-20, Nov.
• Tannista Banerjee & Stephen Martin, 2013, "Pharmaceutical regulation and innovative performance: a decision-theoretic model," Auburn Economics Working Paper Series, Department of Economics, Auburn University, number auwp2013-21, Nov.
• David E. Fagnan & Jose Maria Fernandez & Andrew W. Lo & Roger M. Stein, 2013, "Can Financial Engineering Cure Cancer?," American Economic Review, American Economic Association, volume 103, issue 3, pages 406-411, May, DOI: 10.1257/aer.103.3.406.
• Blanco Orozco, Napoleón Vicente & Zúniga-González, Carlos Alberto, , "Environmental Bio Economic Impact in Nicaragua," Working Papers, National Autonomous University of Nicaragua, León (Unan-León), Researching Center for Applied Economics (RCAE), number 153854, DOI: 10.22004/ag.econ.153854.
• Farasat A. S. Bokhari & Gary M. Fournier, 2013, "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, volume 61, issue 2, pages 339-392, June.
• Frank Lichtenberg & Gisela Hostenkamp, 2013, "The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence," CESifo Working Paper Series, CESifo, number 4516.
• José Morelos Gómez & Fabi�n Gazab�n Arrieta & Roberto Enrique G�mez Fern�ndez, 2013, "Análisis multivariado de la productividad y rendimientos financieros de empresas industriales en Cartagena, Colombia," Apuntes del Cenes, Universidad Pedagógica y Tecnológica de Colombia.
• Alireza AZIMI, 2013, "Identification of External Critical Success Factors in Microbial Biotechnology Firms," Economics and Applied Informatics, "Dunarea de Jos" University of Galati, Faculty of Economics and Business Administration, issue 1, pages 21-26.
• Finger, Stephen R. & Gamper-Rabindran, Shanti, 2013, "Mandatory disclosure of plant emissions into the environment and worker chemical exposure inside plants," Ecological Economics, Elsevier, volume 87, issue C, pages 124-136, DOI: 10.1016/j.ecolecon.2012.12.017.
• Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013, "Margins and market shares: Pharmacy incentives for generic substitution," European Economic Review, Elsevier, volume 61, issue C, pages 116-131, DOI: 10.1016/j.euroecorev.2013.02.005.
• Jayawardhana, Jayani, 2013, "Direct-to-consumer advertising and consumer welfare," International Journal of Industrial Organization, Elsevier, volume 31, issue 2, pages 164-180, DOI: 10.1016/j.ijindorg.2012.09.001.
• Hosken, Daniel & Wendling, Brett, 2013, "Informing the uninformed: How drug advertising affects check-up visits," International Journal of Industrial Organization, Elsevier, volume 31, issue 2, pages 181-194, DOI: 10.1016/j.ijindorg.2010.11.006.
• Anderson, Simon P. & Ciliberto, Federico & Liaukonyte, Jura, 2013, "Information content of advertising: Empirical evidence from the OTC analgesic industry," International Journal of Industrial Organization, Elsevier, volume 31, issue 5, pages 355-367, DOI: 10.1016/j.ijindorg.2013.06.002.
• Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013, "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, volume 31, issue 5, pages 538-553, DOI: 10.1016/j.ijindorg.2013.10.005.
• Chicu, Mark & Ziebarth, Nicolas L., 2013, "Multi-market contact and competition: evidence from the Depression-era portland cement industry," International Journal of Industrial Organization, Elsevier, volume 31, issue 5, pages 603-611, DOI: 10.1016/j.ijindorg.2013.06.001.
• de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges, 2013, "Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?," Journal of Health Economics, Elsevier, volume 32, issue 1, pages 268-285, DOI: 10.1016/j.jhealeco.2012.07.006.
• Ron Boschma & Gaston Heimeriks & Pierre-Alexandre Balland, 2013, "Scientific Knowledge Dynamics and Relatedness in Bio-Tech Cities," Papers in Evolutionary Economic Geography (PEEG), Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, number 1304, Apr, revised Apr 2013.
• Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2013, "Relatedness and Technological Change in Cities: The rise and fall of technological knowledge in U.S. metropolitan areas from 1981 to 2010," Papers in Evolutionary Economic Geography (PEEG), Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, number 1316, Sep, revised Sep 2013.
• Nicolas Houy & Izabela Jelovac, 2013, "Drug launch timing and international reference pricing," Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Etienne (GATE Lyon St-Etienne), Université de Lyon, number 1301.
• Lorenzo Cassi & Anne Plunket, 2013, "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers), HAL, number hal-00987705, Sep, DOI: 10.1080/00343404.2013.816412.
• Lorenzo Cassi & Anne Plunket, 2013, "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Post-Print, HAL, number hal-00987705, Sep, DOI: 10.1080/00343404.2013.816412.
• Nicolas Houy & Izabela Jelovac, 2013, "Drug launch timing and international reference pricing," Post-Print, HAL, number halshs-00861222, May.
• Nicolas Houy & Izabela Jelovac, 2013, "Drug launch timing and international reference pricing," Post-Print, HAL, number halshs-00955848, Jan.
• Nicolas Houy & Izabela Jelovac, 2013, "Drug launch timing and international reference pricing," Working Papers, HAL, number halshs-00782179, Jan.
• Shanti Gamper-Rabindran & Stephen Finger, 2013, "Does industry self-regulation reduce pollution? Responsible Care in the chemical industry," Journal of Regulatory Economics, Springer, volume 43, issue 1, pages 1-30, January, DOI: 10.1007/s11149-012-9197-0.
• Stephen Finger & Shanti Gamper-Rabindran, 2013, "Testing the effects of self-regulation on industrial accidents," Journal of Regulatory Economics, Springer, volume 43, issue 2, pages 115-146, April, DOI: 10.1007/s11149-012-9201-8.